Your search for major depressive disorder returned 24 results

Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).

Cognitive impairment in individuals with major depressive disorder should be treated as a primary problem.

The main focus of the debate surrounding pediatric bipolar disorder pertains to the concept of a prepubertal subtype of the disorder.

There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.

Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.

Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).

People with migraines and comorbid mood disorders often need treatments that address both conditions, as well as management of sleep, stress, and lifestyle issues.

Putative pathogensis insights have grown tremendously in the past 10 years.

Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.

Looking at stress and university students during the COVID-19 pandemic.

In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.

Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.

Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.

Can mere light become a revolutionary new treatment for traumatic brain injury, posttraumatic stress disorder, depression, stroke, Parkinson disease, and Alzheimer disease?

Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.

Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.

Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.

SPECT imaging can be more accurate in the diagnosis of traumatic brain injury and post-traumatic stress disorder than CT or MRI.

Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.

Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.

Two experts speak about how apps address different needs and use different technologies, but taken together, they shed light on the manifold ways that apps can be used for depression management in clinical practice.

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.

This newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.

Depression is one of the most commonly reported complications resulting from stroke.